Zoloft (sertraline hydrochloride)
November 19, 2002
Audience: Psychiatrists and other healthcare professionals
At the request of the FDA, Pfizer issued an important drug warning letter announcing that they have added new information to the CONTRAINDICATIONS and PRECAUTIONS sections of the Zoloft labeling, contraindicating the concomitant use of pimozide with sertraline.[November 2002 Letter - Pfizer] PDF Format
[November 2002 Full, Revised Label, changes highlighted - Pfizer]
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.